Our round-up of recent biotech financings is headed by a $140 million Series D for GRIN Therapeutics, which also scored a $570 million licensing deal with Angelini Pharma. The New York-based biotech ...

You can always count on Chelsea to be busy in the transfer window and it’ll come as no surprise that they’ve already lined up numerous deals this summer. Chelsea are preparing for a new era after ...

A $1.5 billion plan to tear down two New York City Housing Authority complexes in Manhattan and replace them with new high-rise apartments for current tenants is moving forward, city officials say.